Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 43

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 43
---
 | ​ |
| Kiran Nistala(2) | ​ | ​ | ​                   | ​ | 177,357 | ​ | ​ |

(1) Dr. Sidhu transitioned from his role as the Company’s Chief Executive Officer, effective April 8, 2024, and did not receive an annual cash bonus payment for fiscal year 2024. (2) The 2024 bonus amount reported in this table for Dr. Nistala has been converted from GBP to USD using the average exchange rate for the year ended December 31, 2024 of 1 GBP = USD$1.28. Equity-Based Incentive Awards Our equity-based incentive awards granted to our named executive officers are designed to align our interests and those of our shareholders with those of our employees and consultants, including our named executive officers. As of the date of this proxy statement, RSUs and share options were the only form of equity awards we have granted to any of our named executive officers. We use share options as an incentive for long-term compensation to our named executive officers because the share options allow our named executive officers to profit from this form of equity compensation only if our share price increases relative to the share option’s exercise price, which exercise price is set at the fair market value of our Class A ordinary shares on the date of grant. Vesting of equity awards is generally tied to each officer’s continuous service with us and serves as an additional retention measure. We may grant equity awards at such times as the Board or Compensation Committee determines appropriate. Our executives generally are awarded an initial grant in the form of a share option award in connection with their commencement of employment with us. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain corporate goals or to reward executives for exceptional performance. Share options and RSUs typically vest over a period of four years from the date of grant, subject to the named executive officer’s continued service to us through each applicable vesting date. See “— Outstanding Equity Awards at Fiscal Year-End Table.”

25

TABLE OF CONTENTS

Outstanding Equity Awards at Fiscal Year-End Table The following table sets forth information regarding outstanding equity awards for each of our named executive officers as of December 31, 2024. All of the equity awards shown in the table below were granted under our 2023 Equity Incentive Plan (the “2023 Plan”).

| Name           | ​                                                             | ​ | Date Granted |   |              |   | ​                                                               |